메뉴 건너뛰기




Volumn 278, Issue 4, 2015, Pages 410-423

Association between apolipoprotein A-IV concentrations and chronic kidney disease in two large population-based cohorts: Results from the KORA studies

Author keywords

Albuminuria; Apolipoprotein A IV; Chronic kidney disease; Glomerular filtration rate; Kidney function impairment

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A4; CREATININE; APOLIPOPROTEIN A; APOLIPOPROTEIN A-IV;

EID: 84941025931     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12380     Document Type: Article
Times cited : (18)

References (37)
  • 1
    • 79958811114 scopus 로고    scopus 로고
    • The definition, classification, and prognosis of chronic kidney disease: A KDIGO Controversies Conference report
    • Levey AS, de Jong PE, Coresh J et al. The definition, classification, and prognosis of chronic kidney disease: A KDIGO Controversies Conference report. Kidney Int 2011; 80: 17-28.
    • (2011) Kidney Int , vol.80 , pp. 17-28
    • Levey, A.S.1    de Jong, P.E.2    Coresh, J.3
  • 2
    • 4644221457 scopus 로고    scopus 로고
    • Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
    • Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-305.
    • (2004) N Engl J Med , vol.351 , pp. 1296-1305
    • Go, A.S.1    Chertow, G.M.2    Fan, D.3    McCulloch, C.E.4    Hsu, C.Y.5
  • 3
    • 70350741160 scopus 로고    scopus 로고
    • Cardiovascular and noncardiovascular mortality among patients starting dialysis
    • de Jager DJ, Grootendorst DC, Jager KJ et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009; 302: 1782-9.
    • (2009) JAMA , vol.302 , pp. 1782-1789
    • de Jager, D.J.1    Grootendorst, D.C.2    Jager, K.J.3
  • 4
    • 0018689153 scopus 로고
    • Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicrons and free in plasma. Isolation and quantification
    • Utermann G, Beisiegel U. Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicrons and free in plasma. Isolation and quantification. Eur J Biochem 1979; 99: 333-43.
    • (1979) Eur J Biochem , vol.99 , pp. 333-343
    • Utermann, G.1    Beisiegel, U.2
  • 5
    • 0018855123 scopus 로고
    • Human apolipoprotein A-IV. Intestinal origin and distribution in plasma
    • Green PH, Glickman RM, Riley JW, Quinet E. Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. J Clin Invest 1980; 65: 911-9.
    • (1980) J Clin Invest , vol.65 , pp. 911-919
    • Green, P.H.1    Glickman, R.M.2    Riley, J.W.3    Quinet, E.4
  • 6
    • 12444321950 scopus 로고    scopus 로고
    • Plasma distribution of apoA-IV in patients with coronary artery disease and healthy controls
    • Ezeh B, Haiman M, Alber HF et al. Plasma distribution of apoA-IV in patients with coronary artery disease and healthy controls. J Lipid Res 2003; 44: 1523-9.
    • (2003) J Lipid Res , vol.44 , pp. 1523-1529
    • Ezeh, B.1    Haiman, M.2    Alber, H.F.3
  • 7
    • 0025343019 scopus 로고
    • Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells
    • Steinmetz A, Barbaras R, Ghalim N et al. Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. J Biol Chem 1990; 265: 7859-63.
    • (1990) J Biol Chem , vol.265 , pp. 7859-7863
    • Steinmetz, A.1    Barbaras, R.2    Ghalim, N.3
  • 8
    • 0022465661 scopus 로고
    • The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine
    • Stein O, Stein Y, Lefevre M, Roheim PS. The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine. Biochim Biophys Acta 1986; 878: 7-13.
    • (1986) Biochim Biophys Acta , vol.878 , pp. 7-13
    • Stein, O.1    Stein, Y.2    Lefevre, M.3    Roheim, P.S.4
  • 9
    • 0025248437 scopus 로고
    • Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV
    • Goldberg IJ, Scheraldi CA, Yacoub LK, Saxena U, Bisgaier CL. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. J Biol Chem 1990; 265: 4266-72.
    • (1990) J Biol Chem , vol.265 , pp. 4266-4272
    • Goldberg, I.J.1    Scheraldi, C.A.2    Yacoub, L.K.3    Saxena, U.4    Bisgaier, C.L.5
  • 10
    • 0021928993 scopus 로고
    • Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-IV
    • Steinmetz A, Utermann G. Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-IV. J Biol Chem 1985; 260: 2258-64.
    • (1985) J Biol Chem , vol.260 , pp. 2258-2264
    • Steinmetz, A.1    Utermann, G.2
  • 11
    • 0028222323 scopus 로고
    • Comparative effects of purified apolipoproteins A-I, A-II, and A-IV on cholesteryl ester transfer protein activity
    • Guyard-Dangremont V, Lagrost L, Gambert P. Comparative effects of purified apolipoproteins A-I, A-II, and A-IV on cholesteryl ester transfer protein activity. J Lipid Res 1994; 35: 982-92.
    • (1994) J Lipid Res , vol.35 , pp. 982-992
    • Guyard-Dangremont, V.1    Lagrost, L.2    Gambert, P.3
  • 12
    • 0029791322 scopus 로고    scopus 로고
    • Protection against atherogenesis in mice mediated by human apolipoprotein A-IV
    • Duverger N, Tremp G, Caillaud JM et al. Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science 1996; 273: 966-8.
    • (1996) Science , vol.273 , pp. 966-968
    • Duverger, N.1    Tremp, G.2    Caillaud, J.M.3
  • 13
    • 0030944085 scopus 로고    scopus 로고
    • Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV
    • Cohen RD, Castellani LW, Qiao JH et al. Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV. J Clin Invest 1997; 99: 1906-16.
    • (1997) J Clin Invest , vol.99 , pp. 1906-1916
    • Cohen, R.D.1    Castellani, L.W.2    Qiao, J.H.3
  • 14
    • 0033859318 scopus 로고    scopus 로고
    • Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease
    • Kronenberg F, Stuhlinger M, Trenkwalder E et al. Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease. J Am Coll Cardiol 2000; 36: 751-7.
    • (2000) J Am Coll Cardiol , vol.36 , pp. 751-757
    • Kronenberg, F.1    Stuhlinger, M.2    Trenkwalder, E.3
  • 15
    • 0035296412 scopus 로고    scopus 로고
    • The relationship between plasma apolipoprotein A-IV levels and coronary heart disease
    • Manpuya MW, Guo J, Zhao Y. The relationship between plasma apolipoprotein A-IV levels and coronary heart disease. Chin Med J (Engl) 2001; 114: 275-9.
    • (2001) Chin Med J (Engl) , vol.114 , pp. 275-279
    • Manpuya, M.W.1    Guo, J.2    Zhao, Y.3
  • 16
    • 77952911623 scopus 로고    scopus 로고
    • Impact of serum apolipoprotein A-IV as a marker of cardiovascular disease in maintenance hemodialysis patients
    • Omori M, Watanabe M, Matsumoto K et al. Impact of serum apolipoprotein A-IV as a marker of cardiovascular disease in maintenance hemodialysis patients. Ther Apher Dial 2010; 14: 341-8.
    • (2010) Ther Apher Dial , vol.14 , pp. 341-348
    • Omori, M.1    Watanabe, M.2    Matsumoto, K.3
  • 17
    • 33748744794 scopus 로고    scopus 로고
    • Role of the kidney in the metabolism of apolipoprotein A-IV: influence of the type of proteinuria
    • Lingenhel A, Lhotta K, Neyer U et al. Role of the kidney in the metabolism of apolipoprotein A-IV: influence of the type of proteinuria. J Lipid Res 2006; 47: 2071-9.
    • (2006) J Lipid Res , vol.47 , pp. 2071-2079
    • Lingenhel, A.1    Lhotta, K.2    Neyer, U.3
  • 18
    • 0036154170 scopus 로고    scopus 로고
    • Apolipoprotein A-IV serum concentrations are elevated in patients with mild and moderate renal failure
    • Kronenberg F, Kuen E, Ritz E et al. Apolipoprotein A-IV serum concentrations are elevated in patients with mild and moderate renal failure. J Am Soc Nephrol 2002; 13: 461-9.
    • (2002) J Am Soc Nephrol , vol.13 , pp. 461-469
    • Kronenberg, F.1    Kuen, E.2    Ritz, E.3
  • 19
    • 84869889876 scopus 로고    scopus 로고
    • Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus-a post hoc analysis of the 4D Study
    • Kollerits B, Krane V, Drechsler C et al. Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus-a post hoc analysis of the 4D Study. J Intern Med 2012; 272: 592-600.
    • (2012) J Intern Med , vol.272 , pp. 592-600
    • Kollerits, B.1    Krane, V.2    Drechsler, C.3
  • 20
    • 15444365792 scopus 로고    scopus 로고
    • The role of apolipoprotein AIV on the control of food intake
    • Qin X, Tso P. The role of apolipoprotein AIV on the control of food intake. Curr Drug Targets 2005; 6: 145-51.
    • (2005) Curr Drug Targets , vol.6 , pp. 145-151
    • Qin, X.1    Tso, P.2
  • 21
    • 33645452928 scopus 로고    scopus 로고
    • Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study
    • Boes E, Fliser D, Ritz E et al. Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study. J Am Soc Nephrol 2006; 17: 528-36.
    • (2006) J Am Soc Nephrol , vol.17 , pp. 528-536
    • Boes, E.1    Fliser, D.2    Ritz, E.3
  • 22
    • 0029101292 scopus 로고
    • Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis
    • Kronenberg F, Konig P, Neyer U et al. Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1995; 6: 110-20.
    • (1995) J Am Soc Nephrol , vol.6 , pp. 110-120
    • Kronenberg, F.1    Konig, P.2    Neyer, U.3
  • 23
    • 0033866167 scopus 로고    scopus 로고
    • Effects of age, gender, and lifestyle factors on plasma apolipoprotein A-IV concentrations
    • Sun Z, Larson IA, Ordovas JM, Barnard JR, Schaefer EJ. Effects of age, gender, and lifestyle factors on plasma apolipoprotein A-IV concentrations. Atherosclerosis 2000; 151: 381-8.
    • (2000) Atherosclerosis , vol.151 , pp. 381-388
    • Sun, Z.1    Larson, I.A.2    Ordovas, J.M.3    Barnard, J.R.4    Schaefer, E.J.5
  • 24
    • 80355125183 scopus 로고    scopus 로고
    • Do diabetes and depressed mood affect associations between obesity and quality of life in postmenopause? Results of the KORA-F3 Augsburg population study
    • Heidelberg DA, Holle R, Lacruz ME, Ladwig KH, von Lengerke T. Do diabetes and depressed mood affect associations between obesity and quality of life in postmenopause? Results of the KORA-F3 Augsburg population study. Health Qual Life Outcomes 2011; 9: 97.
    • (2011) Health Qual Life Outcomes , vol.9 , pp. 97
    • Heidelberg, D.A.1    Holle, R.2    Lacruz, M.E.3    Ladwig, K.H.4    von Lengerke, T.5
  • 25
    • 84857735644 scopus 로고    scopus 로고
    • Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: the KORA S4/F4 Study
    • Rathmann W, Kowall B, Tamayo T et al. Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: the KORA S4/F4 Study. Ann Med 2012; 44: 170-7.
    • (2012) Ann Med , vol.44 , pp. 170-177
    • Rathmann, W.1    Kowall, B.2    Tamayo, T.3
  • 26
    • 0028174206 scopus 로고
    • Effect of sample storage on the measurement of lipoprotein[a], apolipoproteins B and A-IV, total and high density lipoprotein cholesterol and triglycerides
    • Kronenberg F, Lobentanz EM, Konig P, Utermann G, Dieplinger H. Effect of sample storage on the measurement of lipoprotein[a], apolipoproteins B and A-IV, total and high density lipoprotein cholesterol and triglycerides. J Lipid Res 1994; 35: 1318-28.
    • (1994) J Lipid Res , vol.35 , pp. 1318-1328
    • Kronenberg, F.1    Lobentanz, E.M.2    Konig, P.3    Utermann, G.4    Dieplinger, H.5
  • 27
    • 65649142017 scopus 로고    scopus 로고
    • A new equation to estimate glomerular filtration rate
    • Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-12.
    • (2009) Ann Intern Med , vol.150 , pp. 604-612
    • Levey, A.S.1    Stevens, L.A.2    Schmid, C.H.3
  • 28
    • 84855232027 scopus 로고    scopus 로고
    • Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models
    • Pencina MJ, D'Agostino RB Sr, Demler OV. Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models. Stat Med 2012; 31: 101-13.
    • (2012) Stat Med , vol.31 , pp. 101-113
    • Pencina, M.J.1    D'Agostino Sr, R.B.2    Demler, O.V.3
  • 29
    • 38849091997 scopus 로고    scopus 로고
    • Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond
    • Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-72.
    • (2008) Stat Med , vol.27 , pp. 157-172
    • Pencina, M.J.1    D'Agostino Sr, R.B.2    D'Agostino Jr, R.B.3    Vasan, R.S.4
  • 30
    • 0026576443 scopus 로고
    • Plasma apolipoprotein A-IV metabolism in patients with chronic renal disease
    • Dieplinger H, Lobentanz EM, Konig P et al. Plasma apolipoprotein A-IV metabolism in patients with chronic renal disease. Eur J Clin Invest 1992; 22: 166-74.
    • (1992) Eur J Clin Invest , vol.22 , pp. 166-174
    • Dieplinger, H.1    Lobentanz, E.M.2    Konig, P.3
  • 31
    • 0037408130 scopus 로고    scopus 로고
    • Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients
    • Kronenberg F, Lingenhel A, Neyer U et al. Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients. Kidney Int Suppl 2003; 84: S113-6.
    • (2003) Kidney Int Suppl , vol.84 , pp. S113-S116
    • Kronenberg, F.1    Lingenhel, A.2    Neyer, U.3
  • 32
    • 0035134429 scopus 로고    scopus 로고
    • High serum apolipoprotein AIV levels in renal transplant recipients
    • Massy ZA, Kandoussi AM, Mamzer-Bruneel MF et al. High serum apolipoprotein AIV levels in renal transplant recipients. Clin Nephrol 2001; 55: 156-8.
    • (2001) Clin Nephrol , vol.55 , pp. 156-158
    • Massy, Z.A.1    Kandoussi, A.M.2    Mamzer-Bruneel, M.F.3
  • 33
    • 0023229668 scopus 로고
    • An increased apo A-IV serum concentration of patients with chronic renal failure on hemodialysis
    • Seishima M, Muto Y. An increased apo A-IV serum concentration of patients with chronic renal failure on hemodialysis. Clin Chim Acta 1987; 167: 303-11.
    • (1987) Clin Chim Acta , vol.167 , pp. 303-311
    • Seishima, M.1    Muto, Y.2
  • 34
    • 32644469682 scopus 로고    scopus 로고
    • Immunohistochemical localization of apolipoprotein A-IV in human kidney tissue
    • Haiman M, Salvenmoser W, Scheiber K et al. Immunohistochemical localization of apolipoprotein A-IV in human kidney tissue. Kidney Int 2005; 68: 1130-6.
    • (2005) Kidney Int , vol.68 , pp. 1130-1136
    • Haiman, M.1    Salvenmoser, W.2    Scheiber, K.3
  • 35
    • 0031805581 scopus 로고    scopus 로고
    • Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation
    • Qin X, Swertfeger DK, Zheng S, Hui DY, Tso P. Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation. Am J Physiol 1998; 274: H1836-40.
    • (1998) Am J Physiol , vol.274 , pp. H1836-H1840
    • Qin, X.1    Swertfeger, D.K.2    Zheng, S.3    Hui, D.Y.4    Tso, P.5
  • 36
    • 73849124981 scopus 로고    scopus 로고
    • Emerging risk factors and markers of chronic kidney disease progression
    • Kronenberg F. Emerging risk factors and markers of chronic kidney disease progression. Nat Rev Nephrol 2009; 5: 677-89.
    • (2009) Nat Rev Nephrol , vol.5 , pp. 677-689
    • Kronenberg, F.1
  • 37
    • 73449112003 scopus 로고    scopus 로고
    • Ageing and the glomerular filtration rate: truths and consequences
    • Glassock RJ, Winearls C. Ageing and the glomerular filtration rate: truths and consequences. Trans Am Clin Climatol Assoc 2009; 120: 419-28.
    • (2009) Trans Am Clin Climatol Assoc , vol.120 , pp. 419-428
    • Glassock, R.J.1    Winearls, C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.